Digital hub | Digitalhub

About the program

Scope

Start4Health challenge: Pfizer CDI involves the Greek startup ecosystem in shaping the future of Health

Pfizer CDI pursues to identify and foster ideas that could shape the digital future of Health, exploring the innovative potential of the startup ecosystem.

The start4health is an acceleration program focused on Digital Health and targets startup companies that develop solutions that can tackle challenges of the health industry, improve the digital experience of patients and promote wellness through technology.

Key Thematics

The start4health challenge addresses the Digital Health landscape and its various verticals, looking for technology-enabled products and services that can improve health care delivery and enhance and personalize the treatment experience, such as remote monitoring and support, telemedicine, and wearable devices. It also seeks for digital solutions (such as digital therapeutics) that provide smart data collection and analysis, support prevention, improve the speed and accuracy of diagnosis (e.g. voice based diagnostics), refine the efficiency of care delivery, or raise patient engagement, health literacy and awareness (e.g. prevent fake news).

The aim is to identify and foster innovative ideas, processes and solutions of pioneer technology, with the potential to scale health impact and improve patients’ lives.

Duration

Open Call phase:

28/3 – 29/4

2022

Accelerator Phase:

June – mid July

2022

Apply now >

Who is it for?

Start4Health is addressed to Greek startup companies incubating innovative digital ideas, processes and solutions of pioneer technology, with the potential to scale health impact and improve patients’ lives.Co-creating is a win for everyone

Through the challenge, Pfizer CDI aims to increase its engagement with the regional ecosystem of technology and innovation.

Excellent talents and remarkable teams will have the chance to bring their technology to the limelight and network with notable executives from Pfizer and the Innovation ecosystem.

Further Information can be found in the terms and conditions

Prizes and benefits

1^st Winner

25.000€

Potential collaboration opportunities with Pﬁzer

2^nd Winner

10.000€

Potential collaboration opportunities with Pﬁzer

A judging committee consisting of distinguished members of Technology, Innovation and Business, will select and award the two best proposals with cash prizes of € 25,000 and € 10,000, respectively for the 1st and 2nd winning teams.

Apart from the monetary prizes, the teams via their participation will have the chance to refine their business model, optimize their value propositions, enhance their market position, and potentially score a future collaboration with Pfizer.